Why insider trading matters?

When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.

- Seeking Alpha
Edwards Lifesciences Corp (EW)
Sector: Healthcare; Industry: Medical Devices

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States and internationally. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral valve diseases, as well as various procedure-enabling platforms to advance minimally invasive surgery. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-06-16 Szyman Catherine M. CVP, Critical Care Sell 3,348 $70.67 $236,603 No
2020-06-15 MUSSALLEM MICHAEL A Chairman & CEO Sell 68,550 $68.28 $4,680,286 Yes
2020-06-12 BOBO DONALD E JR CVP, Strategy/Corp Development Sell 13,074 $69.86 $913,313 Yes
2020-06-11 WANG HUIMIN CVP, Japan & Intercontinental Sell 11,733 $71.59 $839,943 Yes
2020-06-11 Szyman Catherine M. CVP, Critical Care Sell 2,249 $72.59 $163,255 No
2020-06-01 Wood Larry L CVP, TAVR Sell 10,698 $75.30 $805,559 Yes
2020-05-18 WANG HUIMIN CVP, Japan & Intercontinental Sell 1,717 $216.68 $372,040 No
2020-05-15 BOBO DONALD E JR CVP, Strategy/Corp Development Sell 4,358 $215.16 $937,667 Yes
2020-05-14 Szyman Catherine M. CVP, Critical Care Sell 1,116 $212.69 $237,362 No
2020-05-13 Szyman Catherine M. CVP, Critical Care Sell 750 $216.93 $162,698 Yes
2020-05-11 WANG HUIMIN CVP, Japan & Intercontinental Sell 3,883 $219.03 $850,495 Yes
2020-05-08 BOBO DONALD E JR CVP, Strategy/Corp Development Sell 5,372 $220.94 $1,186,890 Yes
2020-05-08 MUSSALLEM MICHAEL A Chairman & CEO Sell 22,850 $219.58 $5,017,353 Yes
2020-05-01 Wood Larry L CVP, TAVR Sell 3,566 $215.00 $766,690 Yes
2020-04-27 Lemercier Jean-Luc M CVP, EMEA, Canada, Latin Amer Sell 3,470 $223.50 $775,545 Yes
2020-04-16 Szyman Catherine M. CVP, Critical Care Sell 1,116 $216.91 $242,072 No
2020-04-13 WANG HUIMIN CVP, Japan & Intercontinental Sell 3,911 $212.99 $833,004 Yes
2020-04-07 MUSSALLEM MICHAEL A Chairman & CEO Sell 22,850 $202.34 $4,623,367 Yes
2020-04-03 BOBO DONALD E JR CVP, Strategy/Corp Development Sell 5,369 $182.44 $979,520 Yes
2020-04-01 Wood Larry L CVP, TAVR Sell 3,566 $180.84 $644,875 Yes
2020-04-01 Lemercier Jean-Luc M CVP, EMEA, Canada, Latin Amer Sell 3,470 $180.84 $627,515 Yes
2020-03-30 WANG HUIMIN CVP, Japan & Intercontinental Sell 4,948 $198.10 $980,280 Yes
2020-03-23 Szyman Catherine M. CVP, Critical Care Sell 1,116 $162.95 $181,852 No
2020-03-19 MUSSALLEM MICHAEL A Chairman & CEO Sell 22,850 $177.78 $4,062,339 Yes
2020-03-06 BOBO DONALD E JR CVP, Strategy/Corp Development Sell 5,369 $201.90 $1,084,001 Yes
2020-03-02 Wood Larry L CVP, TAVR Sell 3,566 $207.00 $738,162 Yes
2020-02-27 Lemercier Jean-Luc M CVP, EMEA, Canada, Latin Amer Sell 3,470 $217.53 $754,829 Yes
2020-02-18 Szyman Catherine M. CVP, Critical Care Sell 2,500 $228.57 $571,425 Yes
2020-02-10 MUSSALLEM MICHAEL A Chairman & CEO Sell 22,850 $229.62 $5,246,709 Yes
2020-02-07 BOBO DONALD E JR CVP, Strategy/Corp Development Sell 5,369 $235.65 $1,265,205 Yes

Insider Smart

Celldex Therapeutics, Inc. (CLDX) - Multiple insiders including President, EVP, CEO, CSO and Directors bought shares on Jun.9th, first time since 2018, this was very convincing and we initiated a position. Stock soared from $3 to 9$ in 2 days, and the run is still going on.

Insider Smart

VBI Vaccines Inc (VBIV) - Since 10%-owner Perceptive Advisor LCC increased their holding in April, the stock have double the price. Impressive!